The PULSE study is a German multicentre study for the evaluation of NeoNavia in axillary lymph nodes that has completed patient recruitment and is now in the follow-up stage. The first results are expected to be presented in the autumn of 2021.
NeoDynamics notes the decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics.
NeoDynamics Receives 1st UK Order of Pulse Biopsy System NeoNavia: Product Demos Generating Significant Interest
NeoDynamics reports product demonstrations at several centers have gained significant interest, and the company has now received the first commercial order of its pulse biopsy system including three needle options for all ultrasound led biopsy procedures.